Project Details
Description
UTMB will prepare volumes of Trizol-inactivated serum/plasma derived from selected biosamples from study STDY-21-0008 using a UTMB-approved inactivation procedure and an inactivation certificate will be prepared. UTMB will then coordinate shipment of those inactivated materials to a designated third-party testing laboratory.
| Status | Finished |
|---|---|
| Effective start/end date | 7/15/24 → 12/31/24 |
Funding
- Mapp Biopharmaceutical, Inc ( Award #HHSO100201800024C): $34,565.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.